Key result
Female sex is linked to ~46% higher odds of 30-day mortality after isolated CABG.
Why the study?
The study was conducted to examine sex-specific characteristics in patients undergoing coronary artery bypass grafting at a single institution.
Does female sex increase the risk of 30-day mortality and adverse postoperative outcomes compared to male sex in adult patients undergoing isolated CABG?
Cohort (n=12,736)
No
Does female sex increase the risk of 30-day mortality and adverse postoperative outcomes compared to male sex in adult patients undergoing isolated CABG?
Answers are grounded in this paper and cite their sources.
This large decade-long institutional cohort study demonstrates persistent sex disparities in CABG outcomes, showing that females present with more comorbidities, receive fewer arterial grafts and guideline-directed discharge medications, and face an independently higher risk of 30-day mortality.
Examine sex-specific characteristics in patients undergoing coronary artery bypass grafting (CABG) at our institution. Retrospective chart review was performed utilizing our institutional Society of Thoracic Surgeons (STS) database. An academic, quaternary care center from 2010 to 2021. 3163 females and 9573 males underwent isolated CABG. The institutional STS database was queried for preoperative, intraoperative, and postoperative variables. Univariate comparisons between female and male groups were performed using chi-squared tests or fisher exact tests. Multivariate logistic regression was used to assess risk factors for 30-day mortality. Females had more preoperative comorbidities than males, including hypertension, diabetes, peripheral arterial disease, cerebrovascular disease, renal failure, and prior myocardial infarction. Females more frequently underwent urgent (61 % vs. 58 %) or emergent CABG (5.8 % vs. 4.3 %) compared to males (p < 0.0001). Females experienced longer total intensive care unit (ICU) hours (48.3 h vs. 43.5 h) (p < 0.0001), were more frequently discharged to an extended care facility (13 % vs. 6.4 %) (p < 0.0001) and prescribed less aspirin and beta blocker therapy at discharge than males. In-hospital mortality was higher in females (1.9 % vs. 1.2 %, p = 0.002), as was 30-day mortality (2.7 % vs. 1.6 %, p = 0.0001). Female sex was an independent risk factor for 30-day mortality (odds ratio = 1.46, 95 % CI: 1.06, 2.03, p = 0.02). Over the past decade, females undergoing CABG had more preoperative comorbidities, urgent and emergent operations, longer postoperative ICU stay and a higher risk of mortality than their male counterparts. Further studies must investigate these disparities to improve outcomes for females undergoing CABG.
No takes yet. Share an insight, caveat, or question.
Dassanayake et al. (2023) conducted a cohort in Patients undergoing isolated coronary artery bypass grafting (CABG) (n=12,736). Female sex vs. Male sex was evaluated on 30-day mortality (OR 1.46, 95% CI 1.06, 2.03, p=0.02). Female sex was an independent risk factor for 30-day mortality after isolated CABG (2.7% vs. 1.6%; OR 1.46, 95% CI 1.06-2.03, p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: